FNY Investment Advisers’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Hold
0
895
2023
Q4
Hold
0
807
2023
Q1
Hold
0
790
2022
Q4
Hold
0
815